Strata Critical Medical, Inc. Class A Common Stock (SRTA) Q3 2024 Earnings
Strata Critical Medical, Inc. Class A Common Stock reported Q3 2024 revenue of $74.9M, beat analyst consensus of $51.5M by $23.3M. Diluted EPS came in at $-0.03, beat the $-0.06 consensus by $0.03.
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Strata Critical Medical, Inc. Class A Common Stock's Q3 2024 earnings report.
Strata Critical Medical, Inc. Class A Common Stock (SRTA) reported Q3 2024 earnings on November 12, 2024 before market open.
Strata Critical Medical, Inc. Class A Common Stock reported revenue of $74.9M and diluted EPS of $-0.03 for Q3 2024.
Revenue beat the consensus estimate of $51.5M by $23.3M. EPS beat the consensus estimate of $-0.06 by $0.03.
You can read the 10-Q periodic report (0001779128-24-000126) directly on SEC EDGAR. The filing index links above go to sec.gov.